Coffee drinking and mortality in 10 European countries: A multinational cohort study

Annals of Internal Medicine

Volumn 167, Issue 4, 2017, Pages 236-247

  Gunter, Marc J ^a   Murphy, Neil ^a   Cross, Amanda J ^b   Dossus, Laure ^a   Dartois, Laureen ^c   Fagherazzi, Guy ^c   Kaaks, Rudolf ^d   Kühn, Tilman ^d   Boeing, Heiner ^e   Aleksandrova, Krasimira ^e   Tjønneland, Anne ^f   Olsen, Anja ^f   Overvad, Kim ^g   Larsen, Sofus Christian ^h   Cornejo, Maria Luisa Redondo ⁱ   Agudo, Antonio ^j   Pérez, María José Sánchez ^k   Altzibar, Jone M ^l   Navarro, Carmen ^m   Ardanaz, Eva ⁿ   Khaw, Kay Tee ^o   Butterworth, Adam ^o   Bradbury, Kathryn E ^p   Trichopoulou, Antonia ^q   Lagiou, Pagona ^r   Trichopoulos, Dimitrios ^v   Palli, Domenico ^s   Grioni, Sara ^t   Vineis, Paolo ^b   Panico, Salvatore ^u   Tumino, Rosario ^v   Bueno De Mesquita, Bas ^w   Siersema, Peter ^x   Leenders, Max ^x   Beulens, Joline W J ^x   Uiterwaal, Cuno U ^x   Wallström, Peter ^y   Nilsson, Lena Maria ^z   Landberg, Rikard ^aa   Weiderpass, Elisabete ^ab   Skeie, Guri ^ab   Braaten, Tonje ^ab   Brennan, Paul ^a   Licaj, Idlir ^ab   Muller, David C ^b   Sinha, Rashmi ^ac   Wareham, Nick ^ad   Riboli, Elio ^b   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

^h Mental Health Center Glostrup   (Denmark)

ⁱ PUBLIC HEALTH DIRECTORATE   (Spain)

^j CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^k ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^l Basque Government   (Spain)

^m DEPARTMENT OF EPIDEMIOLOGY   (Spain)

ⁿ INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^o UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^p UNIVERSITY OF OXFORD   (United Kingdom)

^q HELLENIC HEALTH FOUNDATION   (Greece)

^r HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^s CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^t NATIONAL CANCER INSTITUTE   (Italy)

^u UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^v Provincial Health Ragusa ^*

^w NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^x UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^y Departmental Office for Clinical Sciences   (Sweden)

^z UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^aa SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^ab UNIVERSITY OF TROMSØ   (Norway)

^ac NATIONAL CANCER INSTITUTE   (United States)

^ad UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; LIPOPROTEIN A; BIOLOGICAL MARKER; COFFEE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CEREBROVASCULAR DISEASE; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; DRINKING; EUROPEAN; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVARY CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT DISEASE; SUICIDE; BLOOD; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DIGESTIVE SYSTEM DISEASE; EPIDEMIOLOGY; ETHNOLOGY; EUROPE; INFLAMMATION; LIVER FUNCTION TEST; MIDDLE AGED; OVARY TUMOR; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; BIOMARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; COFFEE; DIGESTIVE SYSTEM DISEASES; DRINKING; EUROPE; FEMALE; HUMANS; INFLAMMATION; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MORTALITY; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85027464967     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M16-2945     Document Type: Article

References (45)

1. Gómez-Ruiz JA, Leake DS, Ames JM. In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem. 2007; 55:6962-9. [PMID: 17655324]
2. Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 2006;84:888-93. [PMID: 17023717]
3. Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, van Dam RM. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J. 2011;10:93. [PMID: 21914162] doi:10.1186/1475-2891-10-93
4. Loopstra-Masters RC, Liese AD, Haffner SM, Wagenknecht LE, Hanley AJ. Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function. Diabetologia. 2011;54:320-8. [PMID: 21046357] doi:10.1007/s00125-010-1957-8
5. van Dam RM. Coffee and type 2 diabetes: from beans to beta-cells. Nutr Metab Cardiovasc Dis. 2006;16:69-77. [PMID: 16399494]
6. van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care. 2006;29:398-403. [PMID: 16443894]
7. Lindsted KD, Kuzma JW, Anderson JL. Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality. J Clin Epidemiol. 1992;45:733-42. [PMID: 1619453]
8. Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr. 2006;83:1039-46. [PMID: 16685044]
9. Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health. 1999;53:481-7. [PMID: 10562866]
10. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366:1891-904. [PMID: 22591295] doi:10.1056/NEJMoa1112010
11. Ding M, Satija A, Bhupathiraju SN, Hu Y, Sun Q, Han J, et al. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation. 2015;132:2305-15. [PMID: 26572796] doi:10.1161/CIRCULATIONAHA.115.017341
12. Loftfield E, Freedman ND, Graubard BI, Guertin KA, Black A, Huang WY, et al. Association of coffee consumption with overall and cause-specific mortality in a large US prospective cohort study. Am J Epidemiol. 2015;182:1010-22. [PMID: 26614599] doi:10.1093/aje/kwv146
13. Tverdal A, Stensvold I, Solvoll K, Foss OP, Lund-Larsen P, Bjartveit K. Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. BMJ. 1990;300:566-9. [PMID: 2108750]
14. Rosengren A, Wilhelmsen L. Coffee, coronary heart disease and mortality in middle-aged Swedish men: findings from the Primary Prevention Study. J Intern Med. 1991;230:67-71. [PMID: 2066712]
15. Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB. The relationship of coffee consumption with mortality. Ann Intern Med. 2008;148:904-14. [PMID: 18559841] doi:10.7326/0003-4819-148-12-200806170-00003
16. Sugiyama K, Kuriyama S, Akhter M, Kakizaki M, Nakaya N, Ohmori-Matsuda K, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140:1007-13. [PMID: 20335629] doi:10.3945/jn.109.109314
17. Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol. 2014; 180:763-75. [PMID: 25156996] doi:10.1093/aje/kwu194
18. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997;26 Suppl 1:S6-14. [PMID: 9126529]
19. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5: 1113-24. [PMID: 12639222]
20. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301-9. [PMID: 1626547]
21. Ding P, VanderWeele TJ. Sensitivity analysis without assumptions. Epidemiology. 2016;27:368-77. [PMID: 26841057] doi:10.1097/EDE.0000000000000457
22. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21:2175-97. [PMID: 12210632]
23. Office for National Statistics. Revised European Standard Population 2013 (2013 ESP). 2017. Accessed at www.ons.gov.uk/ons/guide-method/user-guidance/health-and-life-events/revised-european-standard-population-2013-2013-esp-/index.html on 1 April 2017.
24. Tamakoshi A, Lin Y, Kawado M, Yagyu K, Kikuchi S, Iso H; JACC Study Group. Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study. Eur J Epidemiol. 2011;26:285-93. [PMID: 21298466] doi:10.1007/s10654-011-9548-7
25. Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006;166:1190-5. [PMID: 16772246]
26. Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol. 2003;13:419-23. [PMID: 12875799]
27. Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A; Collaborative SIDECIR Group. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol. 2001;11:458-65. [PMID: 11557177]
28. Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol. 1993;9:293-7. [PMID: 8104822]
29. Saab S, Mallam D, Cox GA 2nd, Tong MJ. Impact of coffee on liver diseases: a systematic review. Liver Int. 2014;34:495-504. [PMID: 24102757] doi:10.1111/liv.12304
30. Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner AM. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol. 2008;49:758-67. [PMID: 18486259] doi:10.1016/j.jhep.2008.03.029
31. Shim SG, Jun DW, Kim EK, Saeed WK, Lee KN, Lee HL, et al. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model. J Gastroenterol Hepatol. 2013;28: 1877-84. [PMID: 23808892] doi:10.1111/jgh.12317
32. Vitaglione P, Morisco F, Mazzone G, Amoruso DC, Ribecco MT, Romano A, et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology. 2010;52:1652-61. [PMID: 21038411] doi:10.1002/hep.23902
33. Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, et al; HALT-C Trial Group. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology. 2009;50:1360-9. [PMID: 19676128] doi:10.1002/hep.23162
34. Larsson SC, Virtamo J, Wolk A. Coffee consumption and risk of stroke in women. Stroke. 2011;42:908-12. [PMID: 21393590] doi:10.1161/STROKEAHA.110.603787
35. Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, Logroscino G, Hu FB, van Dam RM. Coffee consumption and risk of stroke in women. Circulation. 2009;119:1116-23. [PMID: 19221216] doi:10.1161/CIRCULATIONAHA.108.826164
36. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al; Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302: 1993-2000. [PMID: 19903920] doi:10.1001/jama.2009.1619
37. Smolders B, Lemmens R, Thijs V. Lipoprotein (a) and stroke: a meta-analysis of observational studies. Stroke. 2007;38:1959-66. [PMID: 17478739]
38. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32:2575-9. [PMID: 11692019]
39. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-43. [PMID: 10733371]
40. Khaw KT, Wareham N. Glycated hemoglobin as a marker of cardiovascular risk. Curr Opin Lipidol. 2006;17:637-43. [PMID: 17095908]
41. Lueth NA, Anderson KE, Harnack LJ, Fulkerson JA, Robien K. Coffee and caffeine intake and the risk of ovarian cancer: the Iowa Women's Health Study. Cancer Causes Control. 2008;19:1365-72. [PMID: 18704717] doi:10.1007/s10552-008-9208-8
42. Braem MG, Onland-Moret NC, Schouten LJ, Tjønneland A, Hansen L, Dahm CC, et al. Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis. Am J Clin Nutr. 2012;95:1172-81. [PMID: 22440851] doi:10.3945/ajcn.111.026393
43. Tworoger SS, Gertig DM, Gates MA, Hecht JL, Hankinson SE. Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer. 2008;112:1169-77. [PMID: 18213613] doi:10.1002/cncr.23275
44. Lucas M, O'Reilly EJ, Pan A, Mirzaei F, Willett WC, Okereke OI, et al. Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults. World J Biol Psychiatry. 2014;15:377-86. [PMID: 23819683] doi:10.3109/15622975.2013.795243
45. Tanskanen A, Tuomilehto J, Viinamäki H, Vartiainen E, Lehtonen J, Puska P. Heavy coffee drinking and the risk of suicide. Eur J Epidemiol. 2000;16:789-91. [PMID: 11297219]